Broadly effective metabolic and immune recovery with C5 inhibition in CHAPLE disease

Author:

Ozen AhmetORCID,Kasap Nurhan,Vujkovic-Cvijin IvanORCID,Apps Richard,Cheung Foo,Karakoc-Aydiner Elif,Akkelle Bilge,Sari Sinan,Tutar Engin,Ozcay Figen,Uygun Dilara Kocacik,Islek Ali,Akgun Gamze,Selcuk Merve,Sezer Oya Balci,Zhang Yu,Kutluk Gunsel,Topal Erdem,Sayar Ersin,Celikel Cigdem,Houwen Roderick H. J.,Bingol Aysen,Ogulur Ismail,Eltan Sevgi Bilgic,Snow Andrew L.,Lake Camille,Fantoni Giovanna,Alba Camille,Sellers Brian,Chauvin Samuel D.ORCID,Dalgard Clifton L.,Harari Olivier,Ni Yan G.,Wang Ming-Dauh,Devalaraja-Narashimha Kishor,Subramanian PooraniORCID,Ergelen Rabia,Artan Reha,Guner Sukru Nail,Dalgic Buket,Tsang John,Belkaid YasmineORCID,Ertem Deniz,Baris Safa,Lenardo Michael J.ORCID

Funder

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Marmara Üniversitesi

Turkish National Society of Allergy and Clinical Immunology

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3